Bioprocessing Application Notes & Case Studies

  1. Maintain Control Of Pharmaceutical Water Systems 4/10/2026

    Early TOC excursions often reveal hidden risks in water systems. Capturing samples at the moment of deviation helps teams confirm root causes faster, reduce uncertainty, and maintain control.

  2. Evaluating Carryover When Using A TOC Analyzer 4/10/2026

    Accurate TOC results shouldn’t depend on sample order. See how low-level measurements remain reliable even after high-TOC analysis, helping reduce false positives and streamline decisions.

  3. Scaling Manufacturing For Global Success 4/7/2026

    This collaboration demonstrates how a partnership-driven approach, combined with technical expertise, can deliver scalable, efficient, and reliable manufacturing solutions that support successful global commercialization.

  4. Ensuring Supply Through Speed And Transparency 4/7/2026

    Through speed, transparency, and close collaboration, the pharmaceutical company was able to switch vendors seamlessly, maintaining virtually uninterrupted manufacturing operations.

  5. In-Line Monitoring Of Culture Medium Using Live Cell Metabolic Analyzer 4/7/2026

    Continuous in-line monitoring of glucose and lactate levels provides highly accurate, real-time data on cellular metabolism without the risks or data gaps associated with manual periodic sampling.

  6. Novel Cardiotoxicity Evaluation Method Using iPS-Derived Cardiomyocytes 4/7/2026

    Discover how real-time monitoring of glucose and lactate in iPS-derived cardiomyocytes reveals subtle drug-induced metabolic shifts that traditional screening methods often fail to detect.

  7. Microbial Integrity Of Sampling Systems After Multiple Actuations 4/6/2026

    Repeated sampling doesn’t have to mean increased contamination risk. See how microbial ingress testing demonstrates sterility integrity after up to 50 sampling actuations.

  8. Tracing PS80: How LC‑MS Resolved A Potency Discrepancy 4/6/2026

    A targeted LC–MS investigation identifies molecular changes behind potency discrepancies, enabling accurate root‑cause analysis and stronger control of monoclonal antibody product quality.

  9. Hunting An Unexpected mAb Variant With LC‑MS 4/6/2026

    A tailored LC–MS approach enables sensitive detection and tracking of monoclonal antibody variants, supporting deeper product characterization and better control of quality‑impacting changes.

  10. Evaluation Of TFF Operating Control Strategies And Scalability 4/2/2026

    Gain insight into a comparison of TMP and permeate control strategies for viral vector TFF, highlighting impacts on flux, processing time, impurity removal, and scale-up predictability across development.